Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NicOx, Ferrer derm deal

NicOx (Euronext:Nicox) partnered its NCX 1022 nitric oxide (NO)-releasing derivative of

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE